Somnus
ID: 353867Type: Posted
Overview

Buyer

DARPA - Biological Technologies Office (DOD-DARPA-BTO)

Eligible Applicants

Others

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Other

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Defense Advanced Research Projects Agency (DARPA) is inviting proposals for the Somnus research initiative, which aims to explore the molecular mechanisms linking gut microbiome interactions and the restorative effects of sleep on cognitive performance. This opportunity is open to all responsible sources capable of meeting the government's needs, with a focus on identifying specific intestinal regions relevant to sleep and immune responses, while adhering to ethical guidelines and providing detailed experimental designs. Up to $2 million in funding is available for individual projects lasting up to 18 months, with proposals due by June 17, 2024. Interested applicants can reach out to Matthew Pava at Somnus@darpa.mil for further information and clarification.

    Point(s) of Contact
    Files
    Title
    Posted
    Amendment 1 to DARPARA2402 introduces a Frequently Asked Questions (FAQ) document relevant to the Somnus Research Announcement (RA). This amendment is limited in scope, as it specifies that no other modifications have been made to the original declaration. The inclusion of the FAQ suggests a desire to clarify processes or expectations associated with the research announcement, likely aimed at supporting potential applicants or stakeholders involved in the grant and proposal processes. By addressing common inquiries, the amendment aims to facilitate a smoother interaction with the RFP and grant guidelines. Overall, this document reflects the government’s effort to enhance transparency and accessibility in the funding and research application process.
    The DARPA Somnus program aims to investigate the effects of sleep deprivation on molecular pathways intertwining the gut and brain. Up to $2 million in funding will be allocated for individual projects lasting up to 18 months, with no limit on collaboration from various institutions, although clear explanations of cooperative efforts are necessary. The Current RA is not a follow-on from the previous Somnus BAA; no awards were made from that. Human research isn’t permitted, and proposals must clarify the intestinal regions chosen for study, based on their relevance to sleep and immune responses. Proposers should detail the number of biospecimens, experimental designs, and ensure adherence to ethical guidelines. Automated methods of sleep deprivation are acceptable, but proposals must include a gold-standard control. Required specimens include blood and fecal samples at various checkpoints, with emphasis on securing sufficient volumes for analyses. The project discourages the use of sugar-based rewards in behavioral tasks. Additionally, alternative data collection methods and analyses outside DARPA specifications are allowed as long as the total costs remain within the funding limit. This structured inquiry is pivotal for understanding host-microbiome interactions under sleep deprivation conditions.
    Similar Opportunities
    Biological Technologies
    DARPA - Biological Technologies Office
    The Defense Advanced Research Projects Agency (DARPA) is inviting proposals for its Biological Technologies initiative under the Broad Agency Announcement (BAA) HR001124S0034. This opportunity seeks innovative research ideas that address topics not currently covered by existing BTO programs, focusing on advancements in biological technologies, machine learning applications in biology, human performance optimization, and biosecurity technologies. The proposals will be evaluated based on scientific merit, relevance to national security, and cost realism, with a submission period running from September 11, 2024, to September 10, 2025. Interested applicants can reach out to the BAA Coordinator at BTOBAA2024@darpa.mil for further information and are encouraged to review the detailed submission guidelines available on SAM.gov.
    Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Interventions to Reduce Sleep Health Disparities," aimed at supporting innovative projects that promote sleep health and address sleep-related health inequalities. This initiative invites applications for non-pharmacological interventions targeting diverse populations experiencing health disparities, particularly focusing on improving sleep health among historically marginalized groups, including racial and ethnic minorities and low socioeconomic populations. The funding opportunity emphasizes the importance of understanding the multi-level determinants affecting sleep health disparities and aims to enhance overall health equity in the U.S. Interested applicants can find more information and submit proposals starting January 5, 2025, with a closing date for applications on September 7, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-330.html.
    Alzheimer’s Research Program Transforming Care Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Care Award to support innovative clinical research aimed at improving care for individuals with Alzheimer's disease and related dementias (AD/ADRD). This funding opportunity encourages community collaboration and requires projects to focus on interventions that enhance the quality of life for both patients and their caregivers. Approximately $5.2 million is available to fund around three awards, with pre-applications due by June 12, 2025, and full applications due by August 29, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    Tactical Behaviors for Autonomous Maneuver
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity through the Tactical Behaviors for Autonomous Maneuver Collaborative Research Program (TBAM-CRP) aimed at enhancing the capabilities of robotic and autonomous systems (RAS) for military operations in complex environments. This program seeks proposals that develop coordinated and adaptive behaviors for small groups of autonomous agents, focusing on innovative maneuver tactics and strategies to operate effectively in multi-domain operations against peer adversaries. The TBAM-CRP is critical for advancing military capabilities, leveraging new technologies in robotics and autonomous systems to improve situational awareness and operational effectiveness on the battlefield. Interested applicants, including institutions of higher education and for-profit organizations, are invited to submit proposals by April 24, 2024, with funding amounts ranging from $100,000 to $2.3 million available per award. For further inquiries, applicants can contact Christopher D. Justice at usarmy.adelphi.devcom-arl.mbx.tbam-crp-questions@army.mil.
    Alzheimer’s Research Program Transforming Diagnosis Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Diagnosis Award to support innovative research aimed at enhancing the diagnosis and prognosis of Alzheimer's disease and related dementias (AD/ADRD). This grant opportunity encourages community collaboration and requires the submission of preliminary data, with a focus on addressing barriers to effective dementia diagnosis. With an estimated total program funding of $3.2 million, the program anticipates awarding two grants, with funding caps set at $1.5 million for single Principal Investigator (PI) proposals and $1.7 million for those utilizing the Career Initiation or Transition Partnership Option. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due by August 29, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)" aimed at advancing innovative research into precision probiotic interventions. This initiative seeks applications that will investigate person-specific factors influencing probiotic responses, such as microbiome composition, age, sex, genetic background, and lifestyle, to identify subgroups that may benefit from tailored probiotic treatments. The funding is crucial for addressing variability in human responses to probiotics and aims to enhance health outcomes through targeted interventions. Applicants can request up to $350,000 per year for a maximum of four years, with the application deadline set for June 2, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-239.html.
    Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the grant opportunity titled "Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)." This initiative aims to support pilot research projects that adapt, optimize, and empirically test behavioral interventions addressing sleep problems in adolescents and young adults who are at risk for mental health disorders. The program emphasizes the importance of developing scalable solutions for sleep-related challenges, particularly for underserved and underrepresented youth populations. Interested applicants can apply for funding of up to $450,000 over three years, with a total of $1.5 million available to fund an estimated six awards in fiscal year 2025. The application deadline is September 30, 2024, and further inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
    Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)" aimed at supporting innovative mechanistic research to develop precision probiotic interventions. This initiative seeks to identify person-specific biological features that influence probiotic responses, thereby enhancing clinical outcomes and addressing the variability in individual responses to probiotics. The funding, which can reach a maximum of $350,000 annually over a combined duration of up to five years, is open to a diverse range of applicants, including educational institutions and nonprofit organizations, while excluding foreign entities. Interested applicants must submit their proposals by June 2, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has announced a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development. This opportunity invites unrestricted applicants to submit proposals aimed at advancing biomedical research and development, with a focus on enhancing human performance. The program is critical for fostering innovation in science and technology, particularly in areas that support the Department of Defense's mission. The estimated total program funding is $10 million, with individual awards ranging from $750,000 to $50 million, and proposals are due by July 31, 2028. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)" aimed at advancing innovative research into the biological factors that influence individual responses to probiotics. This initiative seeks applications that will explore person-specific characteristics, such as genetics, microbiome composition, and lifestyle, to improve the effectiveness of probiotic interventions and address variability in human responses. The total project period is limited to four years, with a maximum budget of $350,000 in direct costs per year, and applications are expected to include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity. Interested applicants can find more information and submission guidelines at the NIH website, with the application deadline set for June 2, 2027, and anticipated awards starting in June 2025. For inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.